This website uses cookies to ensure you get the best experience on our website. Learn more
Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions, nutrition companies as well as leading pharmaceutical and biotech companies. Over 20 case studies and presentations focused on the developments in genome editing techniques and case studies on the therapeutic applications of genome editing. Including 2 interactive streams:
Co-located with the highly established 9th Annual Next Generation Sequencing and Clinical Diagnostics Congress& 5th Annual Single Cell Analysis Congress. There are 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities too.
G.Pavlovic, from PHENOMIN-ICS will present as sponsored speaker (by our partner Charles River):
Lost In translation? Replicating Human Disease With CRISPR/Cas9
• CRISPR/Cas9 genome editing open new possibilities to develop more accurate and predictive models to better understand and treat human disease.
• In this speech, we will present examples of new approaches we developed using CRISPR like CRISMERE (structural variants and CNV models) or large humanization of mouse loci.
• We will also discuss the impact of CRISPR/Cas9 genome editing on the cell genome and present recommendations
-
Congress
